UK Vaccine Approval Sets Worrying Precedent For World Leaders

When the British government authorized Pfizer’s Covid-19 vaccine for mass use on Wednesday, it didn’t take long for backlash to arrive—first and foremost from the European Medicines Agency (EMA), the regulatory entity entrusted with vetting vaccines for the European Union (EU).

Not a day after the announcement, Al Jazeera reported that an EU spokesperson criticized the decision and called the EMA’s own authorization procedures “the most effective regulatory mechanism to grant all EU citizens’ access to a safe and effective vaccine.” Several European legislators also made a point of expressing their disapproval, with one calling the move “problematic” and recommending neighboring countries to not follow suit.

Read full article on Forbes

Originally published on Forbes (December 4, 2020)

© William A. Haseltine, PhD. All Rights Reserved.